Paulson & Co’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,437,666
Closed -$139M 46
2019
Q3
$139M Buy
1,437,666
+679,859
+90% +$68.1M 2.79% 14
2019
Q2
$77.6M Buy
+757,807
New +$81.8M 1.32% 22

Paulson & Co's ONCE Position: Q4 2019 in Review

Paulson & Co sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 1,437,666 shares — an estimated $139M sold.

Paulson & Co first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $139M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Paulson & Co reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Paulson & Co sold 1,437,666 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $139M.
  • Paulson & Co first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • Paulson & Co's Spark Therapeutics, Inc. Common Stock position peaked at $139M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Paulson & Co's 13F filing for Q4 2019, filed 14 Feb 2020.